Celularity Inc. (CELUW) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is neutral — 1 Buy, 2 Hold, 1 Sell.
Analysts estimate Earnings Per Share (EPS) of $-5.70 and revenue of $0.02B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-2.64 vs est $-5.70 (beat +53.7%). Analyst accuracy: 0%.
CELUW Analyst Ratings
Hold
Based on 4 analysts giving stock ratings to Celularity Inc. in the past 3 months
EPS Estimates — CELUW
0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual –$2.64
vs Est –$5.70
▲ 115.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — CELUW
36%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual $0.054B
vs Est $0.020B
▲ 63.8% off
Revenue Trend
Analysts forecast revenue contraction ahead.
